Partow Kebriaei, MD, discusses the potential shift away from transplant in acute lymphoblastic leukemia in light of ongoing advancements.
Partow Kebriaei, MD
Advertisement
Articles by Partow Kebriaei, MD
Partow Kebriaei, MD, discusses the eligibility criteria necessary for patients with acute lymphocytic leukemia to undergo stem cell transplantation.
Partow Kebriaei, MD, discusses the Iomab-B clinical trial for older patients with acute myeloid leukemia.
Advertisement
Latest Updated Articles
Dr. Kebriaei on the Iomab-B Clinical TrialFebruary 24th 2017
Dr. Kebriaei on Eligibility for Stem Cell Transplant in ALLSeptember 12th 2019
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
SERENA-6 Meets PFS2 End Point With Early Switch to Camizestrant in ER+/HER2-Negative, ESR1-Mutated Advanced Breast Cancer
5